SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
AM Almehdi, G Khoder, AS Alchakee, AT Alsayyid… - Infection, 2021 - Springer
Purpose COVID-19 pandemic has emerged as a result of infection by the deadly pathogenic
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing enormous threats …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing enormous threats …
[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
The rise of SARS-CoV-2 variants and the role of convalescent plasma therapy for management of infections
Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARS-Cov-2
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …
Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19
The recent outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China has spread
rapidly around the world, leading to a widespread and urgent effort to develop and use …
rapidly around the world, leading to a widespread and urgent effort to develop and use …
A simplified SARS-CoV-2 pseudovirus neutralization assay
G Donofrio, V Franceschi, F Macchi, L Russo, A Rocci… - Vaccines, 2021 - mdpi.com
COVID-19 is an ongoing pandemic caused by the highly infectious coronavirus SARS-CoV-
2 that is engaging worldwide scientific research to find a timely and effective eradication …
2 that is engaging worldwide scientific research to find a timely and effective eradication …
COVID‐19: risk factors associated with infectivity and severity
COVID‐19 is highly transmissible; however, its severity varies from one individual to
another. Variability among different isolates of the virus and among its receptor (ACE2) may …
another. Variability among different isolates of the virus and among its receptor (ACE2) may …
Regulation of m6A methylation as a new therapeutic option against COVID-19
The rapid spread of SARS-CoV-2 and the resulting pandemic has led to a spasmodic search
for approaches able to limit the diffusion of the disease. The epigenetic machinery has …
for approaches able to limit the diffusion of the disease. The epigenetic machinery has …
[HTML][HTML] Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapy
Monoclonal antibody (mAb) therapy is one of the most promising immunotherapies that have
shown the potential to prevent or neutralize the effects of COVID-19 in patients at very early …
shown the potential to prevent or neutralize the effects of COVID-19 in patients at very early …
Development of a cell-based SARS-CoV-2 pseudovirus neutralization assay using imaging and flow cytometry analysis
JR Izac, EJ Kwee, L Tian, E Elsheikh… - International Journal of …, 2023 - mdpi.com
COVID-19 is an ongoing, global pandemic caused by the novel, highly infectious SARS-CoV-
2 virus. Efforts to mitigate the effects of SARS-CoV-2, such as mass vaccination and …
2 virus. Efforts to mitigate the effects of SARS-CoV-2, such as mass vaccination and …
An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the latest of the several
viral pathogens that have acted as a threat to human health around the world. Thus, to …
viral pathogens that have acted as a threat to human health around the world. Thus, to …